InvestorsHub Logo
Followers 21
Posts 3570
Boards Moderated 0
Alias Born 12/18/2019

Re: B52T38 post# 205240

Monday, 03/07/2022 7:19:18 PM

Monday, March 07, 2022 7:19:18 PM

Post# of 233189
Leronlimab that FAILED to meet ANY CoV protocol endpoints?? What clinical evidence of significant efficacy vs. saline solution -- NONE. Blame anybody else, but the clinical evidence is very clear, there is no reason to approve a failed drug candidate like leronlimab until it meets an clinical endpoint. Even Long-CoV failed to be significant in meeting any endpoint.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News